
50 Annual Report 2022
Baillie Gifford US Growth Trust plc (the ‘Company’) was incorporated
company with registered number 11194060. The Company is an
investment company within the meaning of section 833 of the
Companies Act 2006 and carries on business as an investment trust.
1 Principal Accounting Policies
The Financial Statements for the year to 31 May 2022 have been
prepared in accordance with FRS 102 ‘The Financial Reporting Standard
applicable in the UK and Republic of Ireland’ and on the basis of the
accounting policies set out below.
(a) Basis of Accounting
All of the Company’s operations are of a continuing nature and the
Financial Statements are prepared on a going concern basis under
assumption that approval as an investment trust under section 1158
of the Corporation Tax Act 2010 and the Investment Trust (Approved
Company) (Tax) Regulations 2011 will be retained. The Board has,
in particular, considered the impact of market volatility since the
Covid-19 pandemic but does not believe the Company’s going
concern status is affected. The Company’s assets, the majority
of which are investments in quoted securities which are readily
the prior approval of the Board. Gearing levels and compliance with
borrowing covenants are reviewed by the Board on a regular basis.
As at 31 May 2022, the Company had a net current liability of
revolving credit facility with ING Bank N.V., London Branch, which is
due to mature on 1 August 2023. The Company has continued to
comply with the investment trust status requirements of section 1158
of the Corporation Tax Act 2010 and the Investment Trust (Approved
Company) (Tax) Regulations 2011. The Company’s primary third
party suppliers, including its Managers and Secretaries, Depositary
and Custodian, Registrar, Auditor and Broker, have not experienced
to the Company. Accordingly, the Financial Statements have been
prepared on the going concern basis as it is the Directors’ opinion,
having assessed the principal and emerging risks and other matters
including the impact of the Covid-19 pandemic set out in the Viability
Statement on pages 7 and 8 which assesses the prospects of the
in operational existence for a period of at least twelve months from
the date of approval of these Financial Statements.
The Financial Statements have been prepared in accordance with
the Companies Act 2006, applicable UK Accounting Standards,
the Association of Investment Companies (‘AIC’) Statement of
Recommended Practice ‘Financial Statements of Investment Trust
Companies and Venture Capital Trusts’ issued in November 2014
and updated in April 2021 with consequential amendments. In order to
guidance issued by the AIC, supplementary information which
and capital nature has been presented in the Income Statement.
Although the Company invests in US dollar investments, the Directors
consider the Company’s functional currency to be sterling, as the
Company’s share capital is denominated in sterling, the entity is listed
on a sterling stock exchange in the UK, the Company’s shareholders
are predominantly based in the UK and the Company and its
Manager, who are subject to the UK’s regulatory environment,
are also UK based.
Company’s Balance Sheet when it becomes a party to the
contractual provisions of the instrument.
(b) Accounting Estimates, Assumptions and Judgements
The preparation of the Financial Statements requires the use
of estimates, assumptions and judgements. These estimates,
assumptions and judgements affect the reported amounts of assets
and liabilities at the reporting date. While estimates are based on best
outcome may differ from these estimates. The key sources of estimation
and uncertainty relate to the fair valuation of the unlisted investments.
Judgements
The Directors consider that the preparation of the Financial
Statements involves the following key judgements:
(i) the determination of the functional currency of the Company
as sterling (see rationale in 1(a) above); and
(ii) the fair valuation of the unlisted investments.
The key judgements in the fair valuation process are:
(i) the Managers’ determination of the appropriate application of the
Guidelines 2018 along with the Special Guidelines issued in
March 2020 to each unlisted investment; and
(ii) the Directors’ consideration of whether each fair value is
appropriate following detailed review and challenge. The
judgement applied in the selection of the methodology used
(see 1(c) below) for determining the fair value of each unlisted
Estimates
The key estimate in the Financial Statements is the determination
of the fair value of the unlisted investments by the Managers for
impacts the valuation of the unlisted investments at the Balance
Sheet date. The fair valuation process involves estimation using
subjective inputs that are unobservable (for which market data is
unavailable). The main estimates involved in the selection of the
valuation process inputs are:
(i) the selection of appropriate comparable companies in order to
derive revenue multiples and meaningful relationships between
enterprise value, revenue and earnings growth. Comparable
companies are chosen on the basis of their business
characteristics and growth patterns;
(ii) the selection of a revenue metric (either historical or forecast);
reduced liquidity of unlisted companies versus their listed peers;
(iv) the estimation of the probability assigned to an exit being
through an initial public offering (‘IPO’) or a company sale;
(v) the selection of an appropriate industry benchmark index to
assist with the valuation validation or the application of valuation
adjustments, particularly in the absence of established earnings
or closely comparable peers; and
(vi) the calculation of valuation adjustments derived from milestone
analysis (i.e. incorporating operational success against the plan/
forecasts of the business into the valuation).
Fair value estimates are cross-checked to alternative estimation
methods where possible to improve the robustness of the estimates.
As the valuation outcomes may differ from the fair value estimates a
price sensitivity analysis is provided in Other Price Risk Sensitivity in
note 19 on pages 60 to 63 to illustrate the effect on the Financial
Statements of an over or under estimation of fair values. The risk of
an over or under estimation of fair values is greater when methodologies
are applied using more subjective inputs.
Notes to the Financial Statements
Financial Report